(Q37850559)

24 August 2017

title

A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice (English)

1 reference

24 August 2017

C. muridarum

1 reference

5

1 reference

24 August 2017

Alison Carey

1

1 reference

24 August 2017

Kelly Cunningham

2

1 reference

24 August 2017

Dean Andrew

3

1 reference

24 August 2017

Louise Hafner

4

1 reference

24 August 2017

Kenneth Beagley

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

29

1 reference

24 August 2017

issue

38

1 reference

24 August 2017

page(s)

6505-6513

1 reference

Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Vaccines for Chlamydia infections of the female genital tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Chlamydia trachomatis: impact on human reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Tumor necrosis factor-alpha response to infection with Chlamydia trachomatis in human fallopian tube organ culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

The cellular paradigm of chlamydial pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Live trachoma vaccine and topical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

The effect of trachoma virus vaccine on the course of experimental trachoma infection in blind human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Trachoma vaccine studies in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

The arrested immunity hypothesis and the epidemiology of chlamydia control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Uptake and processing of Chlamydia trachomatis by human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Development of therapeutic HPV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Therapeutic vaccination against HIV: current progress and future possibilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Cytokines and inflammation: modified "Miles-Wilhelm" criteria for assessing the likely roles of these substances in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.07.012

1 reference

release_p7arp3nqfbf5rfrv5xncb4xjcq

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p7arp3nqfbf5rfrv5xncb4xjcq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference